Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Pratima Kunwar"'
Autor:
Mathias Oelke, Emily Lu, Ruipeng Wang, Lauren Suarez, Pratima Kunwar, Daniel Dembrow, Sojung Kim
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss Suppl 2 (2021)
Externí odkaz:
https://doaj.org/article/9f288bbf76b84f9381f8264789481ce9
Autor:
Pratima Kunwar, Natalie Hawkins, Warren L Dinges, Yi Liu, Erin E Gabriel, David A Swan, Claire E Stevens, Janine Maenza, Ann C Collier, James I Mullins, Tomer Hertz, Xuesong Yu, Helen Horton
Publikováno v:
PLoS ONE, Vol 8, Iss 5, p e64405 (2013)
A successful HIV vaccine will likely induce both humoral and cell-mediated immunity, however, the enormous diversity of HIV has hampered the development of a vaccine that effectively elicits both arms of the adaptive immune response. To tackle the pr
Externí odkaz:
https://doaj.org/article/0cde32323f22454ab5a36aef4815d3be
Autor:
David Langan, Keshanti Tidwell, Alison Farrell, Selome Mitiku, Catrina Johnson, Pratima Kunwar, Ruipeng Wang, Sojung Kim, Mathias Oelke
Publikováno v:
Regular and Young Investigator Award Abstracts.
Autor:
Ruipeng Wang, Daniel Dembrow, Emily Lu, Mathias Oelke, Pratima Kunwar, Sojung Kim, Lauren Suarez
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss Suppl 2 (2021)
BackgroundNexImmune is developing highly differentiated immunotherapies to target, activate and expand tumor antigen-specific T cells using the proprietary Artificial Immune Modulation (AIM™) nanotechnology platform. The AIM nanoparticle (AIM-np) t
Publikováno v:
Journal for ImmunoTherapy of Cancer. 9:A106-A106
BackgroundNexImmune is developing highly differentiated immunotherapies to target, activate and expand tumor antigen-specific T cells using the proprietary Artificial Immune Modulation (AIM™) nanotechnology platform. The AIM nanoparticle (AIM-np) t
Autor:
Ramakrishna R. Juventhala, Pratima Kunwar, Michael S. Glickman, Nicholas D. Socci, Allison Fay, Narender Pottabathini, Hakim Djaballah, Han-Guang Yan, Kendra K. Harris
Publikováno v:
ACS Chemical Biology
Bacterial antimicrobial resistance is an escalating public health threat, yet the current antimicrobial pipeline remains alarmingly depleted, making the development of new antimicrobials an urgent need. Here, we identify a novel, potent, imidazoline
Autor:
Helen Horton, Nicholas Lejarcegui, Julie Overbaugh, Barbara Lohman-Payne, Donald L. Sodora, Grace John-Stewart, Jennifer A. Slyker, Grace Itaya, Pratima Kunwar, Elizabeth Maleche-Obimbo, Dalton Wamalwa, Rose Bosire, Melanie A. Gasper
OBJECTIVE To determine neonatal immunologic factors that correlate with mother-to-child-transmission of HIV-1. DESIGN This case-control study compared cord blood natural killer (NK) and T-cell populations of HIV-1 exposed infants who subsequently acq
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9e948f3b48e4539c5a555171beade8a9
https://europepmc.org/articles/PMC4365995/
https://europepmc.org/articles/PMC4365995/
Campylobacter capsule and lipooligosaccharide confer resistance to serum and cationic antimicrobials
Publikováno v:
Virulence. 2(1)
The innate immune system plays a critical role in host defense against mucosal bacteria. Campylobacter jejuni is a major cause of human gastroenteritis that usually resolves spontaneously within several days, suggesting that innate mechanisms are imp
Autor:
Helen Horton, Xuesong Yu, Tomer Hertz, Ann C. Collier, Pratima Kunwar, Natalie Hawkins, Yi Liu, Erin E. Gabriel
Publikováno v:
Europe PubMed Central
Retrovirology
Retrovirology, Vol 9, Iss Suppl 2, p P260 (2012)
Retrovirology
Retrovirology, Vol 9, Iss Suppl 2, p P260 (2012)
Background One of the greatest challenges to develop an efficacious HIV vaccine is the enormous diversity of HIV-1. To tackle this problem, T cells based vaccine approaches have come up with two main camps: the mosaic immunogen camp: increasing the b